US Equity
KURA
— KURA ONCOLOGY, INC.Kura Oncology, Inc. is a clinical-stage biopharmaceutical company that develops precision medicines for the treatment of hematologic malignancies and solid tumors.
💰 Market cap: $901.06M📍 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121 US🏷️ Biotechnology & Medical Research💵 Previous close: $10.39🔢 9,878 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $10.39 |
| 2026-07-23 | $10.45 |
| 2026-07-22 | $10.54 |
| 2026-07-21 | $10.89 |
| 2026-07-20 | $10.68 |
| 2026-07-17 | $10.86 |
| 2026-07-16 | $10.89 |
| 2026-07-15 | $11.33 |
| 2026-07-14 | $11.24 |
| 2026-07-13 | $10.91 |
| 2026-07-10 | $11.45 |
| 2026-07-09 | $12.08 |
| 2026-07-08 | $12.12 |
| 2026-07-07 | $11.99 |
| 2026-07-06 | $11.04 |
| 2026-07-02 | $11.10 |
| 2026-07-01 | $10.78 |
| 2026-06-30 | $10.97 |
| 2026-06-29 | $10.97 |
| 2026-06-26 | $10.90 |
| 2026-06-25 | $10.36 |
| 2026-06-24 | $10.62 |
| 2026-06-23 | $10.38 |
| 2026-06-22 | $10.36 |
| 2026-06-18 | $9.93 |
| 2026-06-17 | $9.57 |
| 2026-06-16 | $9.40 |
| 2026-06-15 | $9.54 |
| 2026-06-12 | $9.05 |
| 2026-06-11 | $8.86 |
| 2026-06-10 | $8.68 |
| 2026-06-09 | $8.81 |
| 2026-06-08 | $8.56 |
| 2026-06-05 | $8.74 |
| 2026-06-04 | $8.77 |
| 2026-06-03 | $8.65 |
| 2026-06-02 | $8.97 |
| 2026-06-01 | $9.04 |
| 2026-05-29 | $10.20 |
| 2026-05-28 | $9.97 |
| 2026-05-27 | $10.24 |
| 2026-05-26 | $10.41 |
| 2026-05-22 | $11.25 |
| 2026-05-21 | $11.13 |
| 2026-05-20 | $10.34 |
| 2026-05-19 | $8.96 |
| 2026-05-18 | $9.20 |
| 2026-05-15 | $9.22 |
| 2026-05-14 | $9.74 |
| 2026-05-13 | $9.48 |
| 2026-05-12 | $9.68 |
| 2026-05-11 | $9.51 |
| 2026-05-08 | $9.42 |
| 2026-05-07 | $9.32 |
| 2026-05-06 | $9.56 |
| 2026-05-05 | $9.29 |
| 2026-05-04 | $9.25 |
| 2026-05-01 | $8.77 |
| 2026-04-30 | $8.83 |
| 2026-04-29 | $8.75 |
| 2026-04-28 | $8.83 |